Bursa Malaysia Announcements | Duopharma Biotech Berhad

Bursa Malaysia Announcement

No	Announcement Date	Company	Title
126	15 NOV 2019	DUOPHARMA BIOTECH BERHAD	DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : DEALINGS OUTSIDE CLOSED PERIOD
125	15 NOV 2019	DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : OTHER ISSUE OF SECURITIES DUOPHARMA BIOTECH BERHAD (FORMERLY KNOWN AS CCM DUOPHARMA BIOTECH BERHAD) ("DUOPHARMA BIOTECH" OR THE "COMPANY") DIVIDEND REINVESTMENT PLAN ("DRP")
124	14 NOV 2019	DUOPHARMA BIOTECH BERHAD	Additional Listing Announcement /Subdivision of Shares
123	11 NOV 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
122	08 NOV 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
121	06 NOV 2019	DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : OTHER ISSUE OF SECURITIES DUOPHARMA BIOTECH BERHAD (FORMERLY KNOWN AS CCM DUOPHARMA BIOTECH BERHAD) ("DUOPHARMA BIOTECH" OR THE "COMPANY") DIVIDEND REINVESTMENT PLAN ("DRP")
120	06 NOV 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
119	05 NOV 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
118	04 NOV 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
117	24 OCT 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
116	23 OCT 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
115	18 OCT 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
114	18 OCT 2019	DUOPHARMA BIOTECH BERHAD	Circular/Notice to Shareholders
113	17 OCT 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
112	16 OCT 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
111	15 OCT 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
110	14 OCT 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
109	11 OCT 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
108	09 OCT 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
107	07 OCT 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
106	04 OCT 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
105	03 OCT 2019	DUOPHARMA BIOTECH BERHAD	DPHARMA - Notice of Book Closure
104	02 OCT 2019	DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : OTHER ISSUE OF SECURITIES DUOPHARMA BIOTECH BERHAD (FORMERLY KNOWN AS CCM DUOPHARMA BIOTECH BERHAD) ("DUOPHARMA BIOTECH" OR THE "COMPANY") DIVIDEND REINVESTMENT PLAN ("DRP")
103	02 OCT 2019	DUOPHARMA BIOTECH BERHAD	Interim Dividend (with Dividend Re-Investment Plan)
102	02 OCT 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
101	01 OCT 2019	DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : OTHER ISSUE OF SECURITIES DUOPHARMA BIOTECH BERHAD (FORMERLY KNOWN AS CCM DUOPHARMA BIOTECH BERHAD) ("DUOPHARMA BIOTECH" OR THE "COMPANY") DIVIDEND REINVESTMENT PLAN ("DRP")
100	01 OCT 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
99	27 SEP 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
98	25 SEP 2019	DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : OTHER ISSUE OF SECURITIES DUOPHARMA BIOTECH BERHAD (FORMERLY KNOWN AS CCM DUOPHARMA BIOTECH BERHAD) ("DUOPHARMA BIOTECH" OR THE "COMPANY") DIVIDEND REINVESTMENT PLAN ("DRP")
97	25 SEP 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
96	23 SEP 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
95	06 SEP 2019	DUOPHARMA BIOTECH BERHAD	Change in Boardroom
94	03 SEP 2019	DUOPHARMA BIOTECH BERHAD	OTHERS DUOPHARMA BIOTECH BERHAD (FORMERLY KNOWN AS CCM DUOPHARMA BIOTECH BERHAD) (DUOPHARMA BIOTECH OR COMPANY) - ACQUISITION OF EQUITY STAKE IN SCM LIFESCIENCE CO., LTD.
93	30 AUG 2019	DUOPHARMA BIOTECH BERHAD	OTHERS Duopharma Biotech Declares 1.0 Sen Interim Dividend For H1 FY2019
92	30 AUG 2019	DUOPHARMA BIOTECH BERHAD	OTHERS DUOPHARMA BIOTECH BERHAD (FORMERLY KNOWN AS CCM DUOPHARMA BIOTECH BERHAD) (DUOPHARMA BIOTECH OR THE COMPANY) INTERIM DIVIDEND
91	30 AUG 2019	DUOPHARMA BIOTECH BERHAD	Quarterly Report on Consolidated Results for the Financial Period Ended 30 June 2019
90	28 AUG 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
89	09 AUG 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
88	02 AUG 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
87	02 AUG 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
86	02 AUG 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
85	31 JULY 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
84	29 JULY 2019	DUOPHARMA BIOTECH BERHAD	OTHERS RENEWAL OF THE MURABAHAH TAWARRUQ TERM FINANCING FACILITY OF RM250 MILLION ("TF-i") AND ISLAMIC MULTI TRADE FACILITIES OF RM30 MILLION ("MTF-i") FROM AMBANK ISLAMIC BERHAD ("AMBANK" OR "BANK")
83	29 JULY 2019	DUOPHARMA BIOTECH BERHAD	DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : DEALINGS OUTSIDE CLOSED PERIOD
82	29 JULY 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
81	29 JULY 2019	DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : OTHER ISSUE OF SECURITIES DUOPHARMA BIOTECH BERHAD ("DUOPHARMA" OR "THE COMPANY") DIVIDEND REINVESTMENT PLAN THAT PROVIDES THE SHAREHOLDERS OF DUOPHARMA THE OPTION TO ELECT TO REINVEST THEIR CASH DIVIDEND IN NEW ORDINARY SHARES IN DUOPHARMA ("DRP")
80	26 JULY 2019	DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : OTHER ISSUE OF SECURITIES DUOPHARMA BIOTECH BERHAD ("DUOPHARMA" OR "THE COMPANY") DIVIDEND REINVESTMENT PLAN THAT PROVIDES THE SHAREHOLDERS OF DUOPHARMA THE OPTION TO ELECT TO REINVEST THEIR CASH DIVIDEND IN NEW ORDINARY SHARES IN DUOPHARMA ("DRP")
79	23 JULY 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
78	19 JULY 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
77	19 JULY 2019	DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : OTHER ISSUE OF SECURITIES DUOPHARMA BIOTECH BERHAD ("DUOPHARMA" OR "THE COMPANY") DIVIDEND REINVESTMENT PLAN THAT PROVIDES THE SHAREHOLDERS OF DUOPHARMA THE OPTION TO ELECT TO REINVEST THEIR CASH DIVIDEND IN NEW ORDINARY SHARES IN DUOPHARMA ("DRP")
76	17 JULY 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
75	16 JULY 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
74	15 JULY 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
73	12 JULY 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
72	04 July 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
71	03 July 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
70	02 July 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
69	01 July 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
68	01 July 2019	DUOPHARMA BIOTECH BERHAD	DIVIDEND REINVESTMENT PLAN STATEMENT, NOTICE OF ELECTION AND DIVIDEND REINVESTMENT FORM
67	28 Jun 2019	DUOPHARMA BIOTECH BERHAD	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RELATED PARTY TRANSACTIONS TERMINATION OF INFORMATION TECHNOLOGY SERVICES AGREEMENT DATED 11 APRIL 2018 BETWEEN CHEMICAL COMPANY OF MALAYSIA BERHAD ("CCMB") AND DUOPHARMA BIOTECH BERHAD ("DUOPHARMA" OR "THE COMPANY") ("IT SERVICES AGREEMENT")
66	28 Jun 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
65	27 Jun 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
64	25 Jun 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
63	21 Jun 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
62	20 Jun 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
61	19 Jun 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
60	18 Jun 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
59	17 Jun 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
58	14 Jun 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
57	14 Jun 2019	DUOPHARMA BIOTECH BERHAD	DPHARMA - Notice of Book Closure
56	13 Jun 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
55	13 Jun 2019	DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : OTHER ISSUE OF SECURITIES DUOPHARMA BIOTECH BERHAD ("DUOPHARMA" OR "THE COMPANY") DIVIDEND REINVESTMENT PLAN THAT PROVIDES THE SHAREHOLDERS OF DUOPHARMA THE OPTION TO ELECT TO REINVEST THEIR CASH DIVIDEND IN NEW ORDINARY SHARES IN DUOPHARMA ("DRP")
54	13 Jun 2019	DUOPHARMA BIOTECH BERHAD	Final Dividend (with Dividend Re-Investment Plan)
53	12 Jun 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
52	10 Jun 2019	DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : OTHER ISSUE OF SECURITIES DUOPHARMA BIOTECH BERHAD ("DUOPHARMA" OR "THE COMPANY") DIVIDEND REINVESTMENT PLAN THAT PROVIDES THE SHAREHOLDERS OF DUOPHARMA THE OPTION TO ELECT TO REINVEST THEIR CASH DIVIDEND IN NEW ORDINARY SHARES IN DUOPHARMA ("DRP")
51	10 Jun 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
50	31 May 2019	DUOPHARMA BIOTECH BERHAD	GENERAL MEETINGS: Outcome of Meeting
49	31 May 2019	DUOPHARMA BIOTECH BERHAD	Change in Boardroom
48	31 May 2019	DUOPHARMA BIOTECH BERHAD	GENERAL MEETINGS: Outcome of Meeting
47	30 May 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
46	29 May 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
45	28 May 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
44	21 May 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
43	21 May 2019	DUOPHARMA BIOTECH BERHAD	Quarterly rpt on consolidated results for the financial period ended 31 Mar 2019
42	17 May 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
41	15 May 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
40	14 May 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
39	13 May 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
38	10 May 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
37	09 May 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
36	07 May 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
35	06 May 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016))
34	03 May 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
33	02 May 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
32	30 April 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
31	29 April 2019	DUOPHARMA BIOTECH BERHAD	Annual Report & CG Report
30	29 April 2019	DUOPHARMA BIOTECH BERHAD	GENERAL MEETINGS: Notice of Meeting
29	26 April 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
28	25 April 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
27	24 April 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
26	23 April 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
25	22 April 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
24	19 April 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
23	18 April 2019	DUOPHARMA BIOTECH BERHAD	DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : DEALINGS OUTSIDE CLOSED PERIOD)
22	18 April 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
21	18 April 2019	DUOPHARMA BIOTECH BERHAD	Changes in Director's Interest (Section 219 of CA 2016)
20	17 April 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
19	16 April 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
18	15 April 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
17	12 April 2019	DUOPHARMA BIOTECH BERHAD	DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : DEALINGS OUTSIDE CLOSED PERIOD
16	12 April 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
15	12 April 2019	DUOPHARMA BIOTECH BERHAD	Changes in Director's Interest (Section 219 of CA 2016)
14	11 April 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
13	18 Mar 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - PERMODALAN NASIONAL BERHAD
12	18 Mar 2019	DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)- YAYASAN PELABURAN BUMIPUTRA
11	27 Feb 2019	CCM DUOPHARMA BIOTECH BERHAD	CCMDBIO - CHANGE OF NAME
10	26 Feb 2019	CCM DUOPHARMA BIOTECH BERHAD	Change of Company Name - DUOPHARMA BIOTECH BERHAD
9	20 Feb 2019	CCM DUOPHARMA BIOTECH BERHAD	OTHERS
8	20 Feb 2019	CCM DUOPHARMA BIOTECH BERHAD	GENERAL MEETINGS: Outcome of Meeting
7	18 Feb 2019	CCM DUOPHARMA BIOTECH BERHAD	Quarterly rpt on consolidated results for the financial period ended 31/12/2018
6	18 Feb 2019	CCM DUOPHARMA BIOTECH BERHAD	OTHERS
5	07 Feb 2019	CCM DUOPHARMA BIOTECH BERHAD	OTHERS
4	14 Jan 2019	CCM DUOPHARMA BIOTECH BERHAD	PROPOSED CHANGE OF THE COMPANY'S NAME FROM "CCM DUOPHARMA BIOTECH BERHAD" TO "DUOPHARMA BIOTECH BERHAD" AND NOTICE OF MEETING OF MEMBERS
3	14 Jan 2019	CCM DUOPHARMA BIOTECH BERHAD	General Meetings: Notice of Meeting
2	11 Jan 2019	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - YAYASAN PELABURAN BUMIPUTRA
1	11 Jan 2019	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - PERMODALAN NASIONAL BERHAD

No	Announcement Date	Company	Title
130	10 Dec 2018	CCM DUOPHARMA BIOTECH BERHAD	Change of Company Name - DUOPHARMA BIOTECH BERHAD
129	29 Nov 2018	CCM DUOPHARMA BIOTECH BERHAD	OTHERS
128	29 Nov 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
127	28 Nov 2018	CCM DUOPHARMA BIOTECH BERHAD	Quarterly rpt on consolidated results for the financial period ended 30 Sep 2018
126	26 Nov 2018	CCM DUOPHARMA BIOTECH BERHAD	Quarterly rpt on consolidated results for the financial period ended 30 Jun 2018
125	23 Nov 2018	CCM DUOPHARMA BIOTECH BERHAD	OTHERS
124	14 Nov 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
123	13 Nov 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
122	12 Nov 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
121	09 Nov 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
120	01 Nov 2018	CCM DUOPHARMA BIOTECH BERHAD	OTHERS
119	25 Oct 2018	CCM DUOPHARMA BIOTECH BERHAD	OTHERS
118	25 Oct 2018	CCM DUOPHARMA BIOTECH BERHAD	OTHERS
117	23 Oct 2018	CCM DUOPHARMA BIOTECH BERHAD	CCMDBIO - Notice of Book Closure
116	22 Oct 2018	CCM DUOPHARMA BIOTECH BERHAD	First Interim Dividend
115	03 Oct 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
114	27 Sep 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
113	12 Sep 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
112	07 Sep 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
111	04 Sep 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
110	03 Sep 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
109	27 Aug 2018	CCM DUOPHARMA BIOTECH BERHAD	OTHERS HIGHER DIVIDEND PAY OUT BASED ON IMPROVED REVENUE AND PROFIT PERFORMANCE FOR H1 2018
108	27 Aug 2018	CCM DUOPHARMA BIOTECH BERHAD	Quarterly rpt on consolidated results for the financial period ended 30 Jun 2018
107	20 Aug 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
106	09 Aug 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - YAYASAN PELABURAN BUMIPUTRA
105	09 Aug 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - PERMODALAN NASIONAL BERHAD
104	07 Aug 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
103	06 Aug 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
102	03 Aug 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
101	02 Aug 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
100	23 Jul 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
99	20 Jul 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) -YAYASAN PELABURAN BUMIPUTRA
98	20 Jul 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) -PERMODALAN NASIONAL BERHAD
97	19 Jul 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
96	18 Jul 2018	CCM DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : OTHER ISSUE OF SECURITIES CCM DUOPHARMA BIOTECH BERHAD ("CCMD" OR "THE COMPANY") DIVIDEND REINVESTMENT PLAN
95	17 Jul 2018	CCM DUOPHARMA BIOTECH BERHAD	Additional Listing Announcement
94	13 Jul 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
93	11 Jul 2018	CCM DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : OTHER ISSUE OF SECURITIES CCM DUOPHARMA BIOTECH BERHAD ("CCMD" OR "THE COMPANY") DIVIDEND REINVESTMENT PLAN
92	10 Jul 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
91	10 Jul 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
90	06 Jul 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
89	05 Jul 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
88	04 Jul 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
87	29 June 2018	CCM DUOPHARMA BIOTECH BERHAD	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RELATED PARTY TRANSACTIONS CCM DUOPHARMA BIOTECH BERHAD ("CCMD" OR "THE COMPANY") PROPOSED ACQUISITION OF 806,450 COMMON SHARES IN PANGEN BIOTECH INC. ("PANGEN") ("PANGEN SHARES") REPRESENTING APPROXIMATELY 8.39% EQUITY INTEREST IN PANGEN FROM CHEMICAL COMPANY OF MALAYSIA BERHAD ("CCMB") FOR A TOTAL PURCHASE CONSIDERATION OF RM59.16 MILLION (EQUIVALENT TO KRW16.35 BILLION) TO BE SATISFIED ENTIRELY IN CASH ("PROPOSED ACQUISITION")
86	27 June 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
70	07 June 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
85	26 June 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
84	25 June 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
83	22 June 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - YAYASAN PELABURAN BUMIPUTRA
82	22 June 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - PERMODALAN NASIONAL BERHAD
81	21 June 2018	CCM DUOPHARMA BIOTECH BERHAD	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RELATED PARTY TRANSACTIONS CCM DUOPHARMA BIOTECH BERHAD ("CCMD" OR "THE COMPANY") PROPOSED ACQUISITION OF 806,450 COMMON SHARES IN PANGEN BIOTECH INC. ("PANGEN") ("PANGEN SHARES") REPRESENTING APPROXIMATELY 8.39% EQUITY INTEREST IN PANGEN FROM CHEMICAL COMPANY OF MALAYSIA BERHAD ("CCMB") FOR A TOTAL PURCHASE CONSIDERATION OF RM59.16 MILLION (EQUIVALENT TO KRW16.35 BILLION) TO BE SATISFIED ENTIRELY IN CASH ("PROPOSED ACQUISITION")
80	20 June 2018	CCM DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES CCM DUOPHARMA BIOTECH BERHAD ("CCMD" OR "THE COMPANY") BONUS ISSUE
79	19 June 2018	CCM DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES CCM DUOPHARMA BIOTECH BERHAD ("CCMD" OR "THE COMPANY") BONUS ISSUE
78	19 June 2018	CCM DUOPHARMA BIOTECH BERHAD	Circular/Notice to Shareholders
77	18 June 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
76	13 June 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
75	13 June 2018	CCM DUOPHARMA BIOTECH BERHAD	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RELATED PARTY TRANSACTIONS CCM DUOPHARMA BIOTECH BERHAD ("CCMD" OR "THE COMPANY") PROPOSED ACQUISITION OF 806,450 COMMON SHARES IN PANGEN BIOTECH INC. ("PANGEN") ("PANGEN SHARES") REPRESENTING APPROXIMATELY 8.39% EQUITY INTEREST IN PANGEN FROM CHEMICAL COMPANY OF MALAYSIA BERHAD ("CCMB") FOR A TOTAL PURCHASE CONSIDERATION OF RM59.16 MILLION (EQUIVALENT TO KRW16.35 BILLION) TO BE SATISFIED ENTIRELY IN CASH ("PROPOSED ACQUISITION")
74	12 June 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
73	11 June 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
72	08 June 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
71	07 June 2018	CCM DUOPHARMA BIOTECH BERHAD	OTHERS ACCEPTANCE OF USD 20.0 MILLION REVOLVING CREDIT-i MURABAHAH FROM OVERSEA-CHINESE BANKING CORPORATION LIMITED, LABUAN BRANCH
69	05 June 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
68	05 June 2018	CCM DUOPHARMA BIOTECH BERHAD	CCMDBIO - Notice of Book Closure
67	05 June 2018	CCM DUOPHARMA BIOTECH BERHAD	CCMDBIO - Notice of Bonus Entitlement
66	04 June 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
65	01 June 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
64	31 May 2018	CCM DUOPHARMA BIOTECH BERHAD	Final Dividend (with Dividend Re-Investment Plan)
63	31 May 2018	CCM DUOPHARMA BIOTECH BERHAD	Bonus Issue
62	31 May 2018	CCM DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : OTHER ISSUE OF SECURITIES CCM DUOPHARMA BIOTECH BERHAD ("CCMD" OR "THE COMPANY") (I) BONUS ISSUE; AND (II) DIVIDEND REINVESTMENT PLAN
61	31 May 2018	CCM DUOPHARMA BIOTECH BERHAD	General Meetings: Outcome of Meeting
60	31 May 2018	CCM DUOPHARMA BIOTECH BERHAD	General Meetings: Outcome of Meeting
59	31 May 2018	CCM DUOPHARMA BIOTECH BERHAD	General Meetings: Outcome of Meeting
58	30 May 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
57	28 May 2018	CCM DUOPHARMA BIOTECH BERHAD	Quarterly rpt on consolidated results for the financial period ended 31/03/2018
56	28 May 2018	CCM DUOPHARMA BIOTECH BERHAD CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
55	25 May 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
54	24 May 2018	CCM DUOPHARMA BIOTECH BERHAD	OTHERS CCM DUOPHARMA BIOTECH BERHAD ("CCMD" or "the Company") - Proposed Internal Restructuring
53	24 May 2018	CCM DUOPHARMA BIOTECH BERHAD	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RELATED PARTY TRANSACTIONS CCM DUOPHARMA BIOTECH BERHAD (CCMD OR COMPANY) (I) GRANT OF LICENSE FOR TRADE MARKS BY CHEMICAL COMPANY OF MALAYSIA BERHAD (CCMB); (II) PURCHASE OF TRADEMARKS FROM CCMB; AND (III) PROVISION OF INFORMATION TECHNOLOGY (IT) SERVICES BY CCMB.
52	24 May 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
51	22 May 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
50	21 May 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
49	17 May 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
48	16 May 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
47	16 May 2018	CCM DUOPHARMA BIOTECH BERHAD	General Meetings: Notice of Meeting
46	16 May 2018	CCM DUOPHARMA BIOTECH BERHAD	CIRCULAR TO SHAREHOLDERS IN RELATION TO THE PROPOSED ACQUISITION OF 806,450 COMMON SHARES IN PANGEN BIOTECH INC. ("PANGEN") REPRESENTING APPROXIMATELY 8.39% EQUITY INTEREST IN PANGEN BY CCM DUOPHARMA BIOTECH BERHAD ("CCMD") FROM CHEMICAL COMPANY OF MALAYSIA BERHAD FOR A TOTAL PURCHASE CONSIDERATION OF RM59.16 MILLION (EQUIVALENT TO KRW16.35 BILLION) TO BE SATISFIED ENTIRELY IN CASH ("PROPOSED ACQUISITION")
45	15 May 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
44	14 May 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
43	07 May 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
42	03 May 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
41	02 May 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
40	30 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
39	30 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	CIRCULAR TO SHAREHOLDERS IN RELATION TO THE (I) PROPOSED BONUS ISSUE OF UP TO 371,945,333 NEW ORDINARY SHARES IN CCMD ("CCMD SHARES" OR" SHARES") ("BONUS SHARES") TO BE CREDITED AS FULLY PAID-UP ON THE BASIS OF 4 BONUS SHARES FOR EVERY 3 EXISTING CCMD SHARES HELD ON AN ENTITLEMENT DATE TO BE DETERMINED AND ANNOUNCED LATER; AND (II) PROPOSED ESTABLISHMENT OF A DIVIDEND REINVESTMENT PLAN WHICH WILL PROVIDE THE SHAREHOLDERS OF CCMD WITH AN OPTION TO ELECT TO REINVEST THEIR CASH DIVIDEND IN THE CCMD SHARES
38	30 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	PROPOSED ADOPTION OF THE NEW CONSTITUTION OF THE COMPANY ("PROPOSED ADOPTION")
37	30 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	Annual Report & CG Report - 2018
36	30 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	General Meetings: Notice of Meeting
35	30 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	General Meetings: Notice of Meeting
34	27 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
33	26 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
32	19 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
31	13 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RELATED PARTY TRANSACTIONS CCM DUOPHARMA BIOTECH BERHAD ("CCMD" OR "THE COMPANY") PROPOSED ACQUISITION OF 806,450 COMMON SHARES IN PANGEN BIOTECH INC. ("PANGEN") ("PANGEN SHARES") REPRESENTING APPROXIMATELY 8.39% EQUITY INTEREST IN PANGEN FROM CHEMICAL COMPANY OF MALAYSIA BERHAD ("CCMB") FOR A TOTAL PURCHASE CONSIDERATION OF RM59.16 MILLION (EQUIVALENT TO KRW16.35 BILLION) TO BE SATISFIED ENTIRELY IN CASH ("PROPOSED ACQUISITION")
30	13 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
29	12 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
28	11 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RELATED PARTY TRANSACTIONS CCM DUOPHARMA BIOTECH BERHAD (CCMD OR COMPANY) (I) GRANT OF LICENSE FOR TRADE MARKS BY CHEMICAL COMPANY OF MALAYSIA BERHAD (CCMB); (II) PURCHASE OF TRADEMARKS FROM CCMB ; AND (III) PROVISION OF INFORMATION TECHNOLOGY (IT) SERVICES BY CCMB. (COLLECTIVELY, THE TRANSACTIONS)
27	11 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : COMBINATION OF NEW ISSUE OF SECURITIES CCM DUOPHARMA BIOTECH BERHAD ("CCMD" OR "THE COMPANY") (I) PROPOSED BONUS ISSUE; AND (II) PROPOSED DIVIDEND REINVESTMENT PLAN
26	10 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	Annual Audited Accounts - 31 Dec 2017
25	10 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
24	03 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
23	02 Apr 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
22	30 Mar 2018	CCM DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : COMBINATION OF NEW ISSUE OF SECURITIES CCM DUOPHARMA BIOTECH BERHAD ("CCMD" OR "THE COMPANY") (I) PROPOSED BONUS ISSUE; AND (II) PROPOSED DIVIDEND REINVESTMENT PLAN
21	29 Mar 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
20	23 Mar 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
19	23 Mar 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
18	16 Mar 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
17	15 Mar 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
15	15 Mar 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
15	14 Mar 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
14	08 Mar 2018	CCM DUOPHARMA BIOTECH BERHAD	Change in Boardroom - DATUK MOHD RADZIF BIN MOHD YUNUS
13	02 Mar 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
12	01 Mar 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
11	01 Mar 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
10	01 Mar 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
9	28 Feb 2018	CCM DUOPHARMA BIOTECH BERHAD	Quarterly rpt on consolidated results for the financial period ended 31/12/2017 (Amended Announcement)
8	27 Feb 2018	CCM DUOPHARMA BIOTECH BERHAD	Quarterly rpt on consolidated results for the financial period ended 31/12/2017
7	27 Feb 2018	CCM DUOPHARMA BIOTECH BERHAD	OTHERS CCM DUOPHARMA BIOTECH BERHAD ("CCMD" or "the Company") - Proposed Internal Restructuring
6	27 Feb 2018	CCM DUOPHARMA BIOTECH BERHAD	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : COMBINATION OF NEW ISSUE OF SECURITIES CCM DUOPHARMA BIOTECH BERHAD ("CCMD" OR "THE COMPANY") (I) PROPOSED BONUS ISSUE; AND (II) PROPOSED DIVIDEND REINVESTMENT PLAN
5	27 Feb 2018	CCM DUOPHARMA BIOTECH BERHAD	OTHERS CCM DUOPHARMA BIOTECH BERHAD ("CCMD" OR "THE COMPANY") - FINAL DIVIDEND
4	17 Jan 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
3	03 Jan 2018	CCM DUOPHARMA BIOTECH BERHAD	Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
2	02 Jan 2018	CCM DUOPHARMA BIOTECH BERHAD	Notice of Person Ceasing (Section 139 of CA 2016) - CHEMICAL COMPANY OF MALAYSIA BERHAD
1	02 Jan 2018	CCM DUOPHARMA BIOTECH BERHAD	Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - CHEMICAL COMPANY OF MALAYSIA BERHAD

No	Announcement Date	Company	Title
44	29 Dec 2017	CCM DUOPHARMA BIOTECH BERHAD	Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - YAYASAN PELABURAN BUMIPUTRA
43	29 Dec 2017	CCM DUOPHARMA BIOTECH BERHAD	Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - PERMODALAN NASIONAL BERHAD
42	27 Dec 2017	CCM DUOPHARMA BIOTECH BERHAD	Change in Boardroom - DATO' AZMI BIN MOHD ALI
41	27 Dec 2017	CCM DUOPHARMA BIOTECH BERHAD	Change in Nomination Committee - DATO' EISAH BINTI A.RAHMAN
40	27 Dec 2017	CCM DUOPHARMA BIOTECH BERHAD	Change in Nomination Committee - DATO' AZMI BIN MOHD ALI
39	27 Dec 2017	CCM DUOPHARMA BIOTECH BERHAD	Change in Nomination Committee - TAN SRI SITI SA'DIAH BINTI SH BAKIR
38	27 Dec 2017	CCM DUOPHARMA BIOTECH BERHAD	Change in Nomination Committee - DATO' MOHAMAD KAMARUDIN BIN HASSAN
37	27 Dec 2017	CCM DUOPHARMA BIOTECH BERHAD	Change in Principal Officer - ENCIK LEONARD ARIFF BIN ABDUL SHATAR
36	27 Dec 2017	CCM DUOPHARMA BIOTECH BERHAD	Change in Boardroom - DATUK NIK MOUSTPHA BIN HJ NIK HASSAN
35	27 Dec 2017	CCM DUOPHARMA BIOTECH BERHAD	Change in Boardroom - TAN SRI SITI SA'DIAH BINTI SH BAKIR
34	27 Dec 2017	CCM DUOPHARMA BIOTECH BERHAD	Change of Company Secretary - IBRAHIM HUSSIN SALLEH
33	27 Dec 2017	CCM DUOPHARMA BIOTECH BERHAD	Change of Company Secretary - NOOR AZWAH BINTI SAMSUDIN
32	27 Dec 2017	CCM DUOPHARMA BIOTECH BERHAD	Change in Boardroom - ENCIK LEONARD ARIFF BIN ABDUL SHATAR
31	27 Dec 2017	CCM DUOPHARMA BIOTECH BERHAD	Change in Boardroom - DATO' NORMALA BINTI ABDUL SAMAD
30	22 Dec 2017	CCM DUOPHARMA BIOTECH BERHAD	OTHERS CONTRACT FOR THE SUPPLY OF PHARMACEUTICAL AND/OR NON-PHARMACEUTICAL PRODUCTS TO HOSPITALS, CLINICS AND OTHERS UNDER THE GOVERNMENT OF MALAYSIA
29	22 Dec 2017	CCM DUOPHARMA BIOTECH BERHAD	DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : DEALINGS OUTSIDE CLOSED PERIOD
28	04 Dec 2017	CCM DUOPHARMA BIOTECH BERHAD	OTHERS LEONARD ARIFF MANDATED TO SPEARHEAD CCMD AS GROUP MANAGING DIRECTOR
27	17 Nov 2017	CCM DUOPHARMA BIOTECH BERHAD	Quarterly rpt on consolidated results for the financial period ended 30/09/2017
26	25 Sep 2017	CCM DUOPHARMA BIOTECH BERHAD	Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - CHEMICAL COMPANY OF MALAYSIA BERHAD
25	25 Sep 2017	CCM DUOPHARMA BIOTECH BERHAD	Notice of Person Ceasing (Section 139 of CA 2016) - CCM MARKETING SDN BHD
24	29 Aug 2017	CCM DUOPHARMA BIOTECH BERHAD	CCMDBIO - Notice of Book Closure
23	25 Aug 2017	CCM DUOPHARMA BIOTECH BERHAD	Interim Dividend
22	25 Aug 2017	CCM DUOPHARMA BIOTECH BERHAD	Quarterly rpt on consolidated results for the financial period ended 30/06/2017
21	22 Aug 2017	CCM DUOPHARMA BIOTECH BERHAD	OTHERS ACCEPTANCE OF TENDER OFFER (HEREINAFTER REFERRED TO AS LETTER OF AWARD) FOR THE SUPPLY OF HUMAN INSULIN FORMULATIONS (HEREINAFTER REFERRED TO AS PRODUCTS) UNDER MINISTRY OF HEALTHS (MOH) OFF-TAKE AGREEMENT PROGRAM
20	02 Aug 2017	CCM DUOPHARMA BIOTECH BERHAD	CCMDBIO - RESUMPTION OF TRADING
19	02 Aug 2017	CCM DUOPHARMA BIOTECH BERHAD	OTHERS Reference to Announcement on Corporate Proposal by Chemical Company of Malaysia Berhad ("CCMB")
18	02 Aug 2017	CCM DUOPHARMA BIOTECH BERHAD	SUSPENSION OF SECURITIES
17	02 Aug 2017	CCM DUOPHARMA BIOTECH BERHAD	CCMDBIO - Suspension of Trading
16	06 Jul 2017	CCM DUOPHARMA BIOTECH BERHAD	OTHERS ACCEPTANCE OF CREDIT FACILITIES FROM OCBC BANK (MALAYSIA) BERHAD OF UP TO RM19.55 MILLION
15	20 Jun 2017	CCM DUOPHARMA BIOTECH BERHAD	OTHERS ACCEPTANCE OF MURABAHAH TAWARRUQ TERM FINANCING FACILITY OF RM250 MILLION (TF-i) AND ISLAMIC MULTI TRADE FACILITIES OF RM30 MILLION (MTF-i) FROM AMBANK ISLAMIC BERHAD (AMBANK OR BANK)
14	22 May 2017	CCM DUOPHARMA BIOTECH BERHAD	General Meetings: Outcome of Meeting
13	22 May 2017	CCM DUOPHARMA BIOTECH BERHAD	Quarterly rpt on consolidated results for the financial period ended 31/03/2017
12	27 Apr 2017	CCM DUOPHARMA BIOTECH BERHAD	Proposed Renewal of Existing Shareholders' Mandate for Recurrent Related Party Transactions of a Revenue or Trading Nature ("Proposed Shareholders' Mandate")
11	27 Apr 2017	CCM DUOPHARMA BIOTECH BERHAD	Annual Report - 2016
10	27 Apr 2017	CCM DUOPHARMA BIOTECH BERHAD	General Meetings: Notice of Meeting
9	06 Apr 2017	CCM DUOPHARMA BIOTECH BERHAD	DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : DEALINGS OUTSIDE CLOSED PERIOD
8	28 Feb 2017	CCM DUOPHARMA BIOTECH BERHAD	CCMDBIO - Notice of Book Closure
7	24 Feb 2017	CCM DUOPHARMA BIOTECH BERHAD	Change in Boardroom - DR BYUNG-GEON RHEE
6	24 Feb 2017	CCM DUOPHARMA BIOTECH BERHAD	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RECURRENT RELATED PARTY TRANSACTIONS PROPOSED RENEWAL OF EXISTING SHAREHOLDERS' MANDATE FOR RECURRENT RELATED PARTY TRANSACTIONS OF A REVENUE OR TRADING NATURE ("PROPOSED SHAREHOLDERS' MANDATE")
5	24 Feb 2017	CCM DUOPHARMA BIOTECH BERHAD	Final Dividend
4	24 Feb 2017	CCM DUOPHARMA BIOTECH BERHAD	Quarterly rpt on consolidated results for the financial period ended 31/12/2016
3	15 Feb 2017	CCM DUOPHARMA BIOTECH BERHAD	OTHERS SUCCESSFUL COMPLETION OF JOINTLY CONDUCTED MULTINATIONAL PHASE III CLINICAL TRIAL FOR BIOSIMILAR ERYTHROPOIETIN
2	26 Jan 2017	CCM DUOPHARMA BIOTECH BERHAD	OTHERS CLARIFICATION WITH RESPECT TO THE ANNOUNCEMENT DATED 25 JANUARY 2017 ON ACCEPTANCE OF TENDER OFFER (HEREINAFTER REFERRED TO AS "LETTER OF AWARD") FOR THE SUPPLY OF HUMAN INSULIN FORMULATIONS (HEREINAFTER REFERRED TO AS "PRODUCTS") UNDER MINISTRY OF HEALTH'S OFF-TAKE AGREEMENT PROGRAM
1	25 Jan 2017	CCM DUOPHARMA BIOTECH BERHAD	OTHERS ACCEPTANCE OF TENDER OFFER (HEREINAFTER REFERRED TO AS LETTER OF AWARD) FOR THE SUPPLY OF HUMAN INSULIN FORMULATIONS (HEREINAFTER REFERRED TO AS PRODUCTS) UNDER MINISTRY OF HEALTHS (MOH) OFF-TAKE AGREEMENT PROGRAM